Stocks · News reference
CVRx Sees Q3 Sales $13.500M-$14.500M vs $16.840M Est
CVRx (NASDAQ:CVRX) sees Q3 sales of $13.500 million-$14.500 million vs $16.840 million analyst estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 8:32 PM
- Checked
- Aug 6, 2026, 8:32 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
CVRx Shareholder Urges Board To Launch Sale Process To Unlock Barostim’s Strategic Value
Read original at benzingaCVRx Announces Devoted Health Issued Medicare Advantage Coverage Policy For Barostim Effective July 17
Read original at benzingaCVRx shares are trading lower after Cantor Fitzgerald lowered its price target on the stock from $13 to $5.
Read original at benzinga